Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview studyJustin Presseau, Dean Fergusson, Terry Hawrysh et al.|Trials|2021Cited by 25
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Justin Presseau, Sarah Asad et al.|BMJ Open|2021Cited by 23
Pro‐tolerogenic effects of photodynamic therapy with TH9402 on dendritic cellsRaewyn Broady, Megan K. Levings, Jie Yu|Journal of Clinical Apheresis|2008Cited by 16